title: Tenofovir-related nephrotoxicity: an ongoing clinical challenge.
authors.forename: Michelle M
authors.initials: MM
authors.lastname: Foisy
authors.forename: Christine
authors.initials: C
authors.lastname: Hughes
authors.forename: Cara
authors.initials: C
authors.lastname: Hills-Nieminen
authors.forename: Ameeta E
authors.initials: AE
authors.lastname: Singh
authors.forename: A Mark
authors.initials: AM
authors.lastname: Joffe
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors; D000068698:Tenofovir
chemical_list: D019380:Anti-HIV Agents; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine